FOSB inactivation in mast cells has been shown to increase the inflammatory response (Duque-Wilckens et al., 2021), and it has contradictorily also been reported to be upregulated in single cell analysis of CD4+ T-cells of severe COVID-19 patients (Kalfaoglu et al., 2020). The gene discussed is CD4; the disease is COVID-19.